Randomized clinical trial of topical tranexamic acid after reduction mammoplasty

British Journal of Surgery

Volumn 102, Issue 11, 2015, Pages 1348-1353

  Ausen, K ^a   Fossmark, R ^a,b   Spigset, O ^a,b   Pleym, H ^a,c  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b Intensive Care St Olav's University Hospital ^*  (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

ADOLESCENT; ADULT; AGED; BREAST RECONSTRUCTION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANTIFIBRINOLYTIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMAPLASTY; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; TRANEXAMIC ACID; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84941044477     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9878     Document Type: Article

References (37)

1. Dunn CJ, Goa KL,. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57: 1005-1032.
2. Ker K, Prieto-Merino D, Roberts I,. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg 2013; 100: 1271-1279.
3. Ker K, Edwards P, Perel P, Shakur H, Roberts I,. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344: e3054.
4. Ngaage DL, Bland JM,. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies. Eur J Cardiothorac Surg 2010; 37: 1375-1383.
5. Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL,. The dose-response relationship of tranexamic acid. Anesthesiology 1995; 82: 383-392.
6. Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, et al,. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ 2014; 349: g4829.
7. Yee BE, Wissler RN, Zanghi CN, Feng C, Eaton MP,. The effective concentration of tranexamic acid for inhibition of fibrinolysis in neonatal plasma in vitro. Anesth Analg 2013; 117: 767-772.
8. Andersson L, Eriksson O, Hedlund PO, Kjellman H, Lindqvist B,. Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. Urol Res 1978; 6: 83-88.
9. Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL, et al,. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 2002; 97: 390-399.
10. Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M,. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010; 110: 350-353.
11. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, et al,. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011; (3)CD001886.
12. Koster A, Schirmer U,. Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era. Curr Opin Anaesthesiol 2011; 24: 92-97.
13. Ker K, Roberts I,. Tranexamic acid for surgical bleeding. BMJ 2014; 349: g4934.
14. Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, et al,. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 2010; 92: 2503-2513.
15. De Bonis M, Cavaliere F, Alessandrini F, Lapenna E, Santarelli F, Moscato U, et al,. Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study. J Thorac Cardiovasc Surg 2000; 119: 575-580.
16. Ipema HJ, Tanzi MG,. Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures. Ann Pharmacother 2012; 46: 97-107.
17. Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, Pérez-Chrzanowska H, Figueredo-Zalve R,. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am 2014; 96: 1937-1944.
18. Wind TC, Barfield WR, Moskal JT,. The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty. J Arthroplasty 2013; 28: 1080-1083.
19. Wang H, Shen B, Zeng Y,. Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee 2014; 21: 987-993.
20. Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM,. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J 2014; 96-b: 1005-1015.
21. Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE,. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. J Arthroplasty 2014; 29: 1512-1515.
22. Abrishami A, Chung F, Wong J,. Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis. Can J Anaesth 2009; 56: 202-212.
23. Zahed R, Moharamzadeh P, Alizadeharasi S, Ghasemi A, Saeedi M,. A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial. Am J Emerg Med 2013; 31: 1389-1392.
24. Sarris I, Arafa A, Konaris L, Kadir RA,. Topical use of tranexamic acid to control perioperative local bleeding in gynaecology patients with clotting disorders: two cases. Haemophilia 2007; 13: 115-116.
25. Tang YM, Chapman TW, Brooks P,. Use of tranexamic acid to reduce bleeding in burns surgery. J Plast Reconstr Aesthet Surg 2012; 65: 684-686.
26. Hinder D, Tschopp K,. [Topical application of tranexamic acid to prevent post-tonsillectomy haemorrhage.] Laryngorhinootologie 2015; 94: 86-90.
27. Athanasiadis T, Beule AG, Wormald PJ,. Effects of topical antifibrinolytics in endoscopic sinus surgery: a pilot randomized controlled trial. Am J Rhinol 2007; 21: 737-742.
28. Patatanian E, Fugate SE,. Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction. Ann Pharmacother 2006; 40: 2205-2210.
29. Barnard J, Millner R,. A review of topical hemostatic agents for use in cardiac surgery. Ann Thorac Surg 2009; 88: 1377-383.
30. Sterling JP, Heimbach DM,. Hemostasis in burn surgery-a review. Burns 2011; 37: 559-565.
31. Walsh K, Nikkhah D, Dheansa B,. What is the evidence for tranexamic acid in burns? Burns 2014; 40: 1055-1057.
32. Kjersti A,. 20 ml Fluid on AquaDoodle Canvas. https://youtu.be/10AkwMQSE1s [accessed 1 March 2015 ].
33. Paired t-test. http://www.biomath.info/power/prt.htm [accessed 2 January 2012 ].
34. Lehmann EL,. Comparing two treatments of attributes in a population model. In: Nonparametrics: Statistical Methods Based on Ranks, Lehmann EL, (ed). Springer: New York, 1998; 76-81.
35. Stojkovic CA, Smeulders MJ, Van der Horst CM, Khan SM,. Wound drainage after plastic and reconstructive surgery of the breast. Cochrane Database Syst Rev 2013; (3)CD007258.
36. Overbosch HC, Hart HC,. Local application of epsilon-aminocaproic acid (E.A.C.A.) in the prevention of haemorrhage after tonsillectomy. J Laryngol Otol 1970; 84: 905-908.
37. Ker K, Beecher D, Roberts I,. Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database Syst Rev 2013; (7)CD010562.